Medtronic
MDT
2,021 hedge funds and large institutions have $95.6B invested in Medtronic in 2022 Q2 according to their latest regulatory filings, with 114 funds opening new positions, 855 increasing their positions, 807 reducing their positions, and 167 closing their positions.
91% more call options, than puts
Call options by funds: $943M | Put options by funds: $494M
6% more repeat investments, than reductions
Existing positions increased: 855 | Existing positions reduced: 807
0.15% less ownership
Funds ownership: 80.74% → 80.59% (-0.15%)
4% less funds holding
Funds holding: 2,101 → 2,021 (-80)
18% less funds holding in top 10
Funds holding in top 10: 39 → 32 (-7)
32% less first-time investments, than exits
New positions opened: 114 | Existing positions closed: 167
42% less capital invested
Capital invested by funds: $165B → $95.6B (-$69.1B)
Top Buyers
| 1 |
Barclays
London,
United Kingdom
|
+$433M |
| 2 |
Capital Research Global Investors
Los Angeles,
California
|
+$406M |
| 3 |
Morgan Stanley
New York
|
+$256M |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$250M |
| 5 |
BlackRock
New York
|
+$242M |
Top Sellers
MDT Hedge Fund Activity: Q2 2022 in Review
2,021 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Medtronic (MDT) for Q2 2022, worth a combined $95.6B — down 42% from $165B a quarter earlier.
Sellers outnumbered buyers: 167 funds closed out of MDT and 114 opened new positions — a net loss of 53 holders — while 807 trimmed existing stakes and 855 added.
The largest buyer was Barclays, adding an estimated $433M. The largest seller was T. Rowe Price Associates, cutting an estimated $795M.
- 2,021 institutional investors held Medtronic (MDT) as of Q2 2022, down from 2,101 in Q1 2022.
- Funds reported $95.6B of Medtronic stock for Q2 2022, down 42% quarter-over-quarter.
- 114 funds opened new Medtronic positions in Q2 2022 and 167 closed out, a net change of -53 holders.
- The largest Medtronic buyer in Q2 2022 was Barclays, an estimated $433M added.
- The largest Medtronic seller in Q2 2022 was T. Rowe Price Associates, an estimated $795M sold.
Based on aggregated 13F filings for Q2 2022.